MDM2 and cancer: Overexpression of MDM2 gene leads to a growth/survival advantage for cancer cells not only by p53 inhibition but also by induction of p53-independent pro-survival mechanisms, including inhibition of tumor suppressor activity of retinoblastoma (Rb) [41] or (E2F transcription factor 1) (E2F1) [42].